Supplements

A supplement to Dermatology News

Articles include:

• Expert shares new insights on the pathophysiology of rosacea
• Acne and diet: Still no solid basis for dietary recommendations
• Rosacea research reveals advances, promising therapies
• Study identifies link between rosacea and several GI disorders
• Caution is key when prescribing spironolactone for adult acne
• Commentary by Dr. Julie C. Harper
• And more …

Faculty:

Julie C. Harper, M.D.
Dr. Harper is a dermatologist in private practice in Alabama at the Dermatology and Skin Care Center of Birmingham. She was a member of the American Academy of Dermatology work group that developed the AAD’s updated guidelines for the management of acne vulgaris, published in February 2016, and is the current president of the American Acne & Rosacea Society. She is also a clinical associate professor at the University of Alabama, Birmingham. Dr. Harper has been a speaker for Allergan, Bayer, Galderma, La Roche-Posay, SkinCeuticals, and Valeant Pharmaceuticals. She is also an investigator for Bayer and an advisory board member for Allergan, Bayer, BioPharmX, Galderma, and Valeant.

Click here to view the supplement

©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.

A supplement to Dermatology News

Articles include:

• Expert shares new insights on the pathophysiology of rosacea
• Acne and diet: Still no solid basis for dietary recommendations
• Rosacea research reveals advances, promising therapies
• Study identifies link between rosacea and several GI disorders
• Caution is key when prescribing spironolactone for adult acne
• Commentary by Dr. Julie C. Harper
• And more …

Faculty:

Julie C. Harper, M.D.
Dr. Harper is a dermatologist in private practice in Alabama at the Dermatology and Skin Care Center of Birmingham. She was a member of the American Academy of Dermatology work group that developed the AAD’s updated guidelines for the management of acne vulgaris, published in February 2016, and is the current president of the American Acne & Rosacea Society. She is also a clinical associate professor at the University of Alabama, Birmingham. Dr. Harper has been a speaker for Allergan, Bayer, Galderma, La Roche-Posay, SkinCeuticals, and Valeant Pharmaceuticals. She is also an investigator for Bayer and an advisory board member for Allergan, Bayer, BioPharmX, Galderma, and Valeant.

Click here to view the supplement

©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.

A supplement to Dermatology News

Articles include:

• Expert shares new insights on the pathophysiology of rosacea
• Acne and diet: Still no solid basis for dietary recommendations
• Rosacea research reveals advances, promising therapies
• Study identifies link between rosacea and several GI disorders
• Caution is key when prescribing spironolactone for adult acne
• Commentary by Dr. Julie C. Harper
• And more …

Faculty:

Julie C. Harper, M.D.
Dr. Harper is a dermatologist in private practice in Alabama at the Dermatology and Skin Care Center of Birmingham. She was a member of the American Academy of Dermatology work group that developed the AAD’s updated guidelines for the management of acne vulgaris, published in February 2016, and is the current president of the American Acne & Rosacea Society. She is also a clinical associate professor at the University of Alabama, Birmingham. Dr. Harper has been a speaker for Allergan, Bayer, Galderma, La Roche-Posay, SkinCeuticals, and Valeant Pharmaceuticals. She is also an investigator for Bayer and an advisory board member for Allergan, Bayer, BioPharmX, Galderma, and Valeant.

Click here to view the supplement

©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.

Click Here to Read Supplement. 

Topics Include:

• The Role of Cord Blood Stem Cells
• Impact of DCC in Cord Blood Collection
• Combining DCC and Cord Blood Collection
• When to Clamp the Umbilical Cord

Faculty/Faculty Disclosure:

Fung Lam, MD
Chair-GYN Quality, Director of Medical Education (OB-GYN), California-Pacific Medical Center
Senior Partner, Golden Gate Obstetrics & Gynecology
Clinical Professor-Department of Obstetrics, Gynecology and Reproductive Sciences
University of California, San Francisco
San Francisco, California

Click Here to Read the Supplement. 

Click Here to Read Supplement. 

Topics Include:

• The Role of Cord Blood Stem Cells
• Impact of DCC in Cord Blood Collection
• Combining DCC and Cord Blood Collection
• When to Clamp the Umbilical Cord

Faculty/Faculty Disclosure:

Fung Lam, MD
Chair-GYN Quality, Director of Medical Education (OB-GYN), California-Pacific Medical Center
Senior Partner, Golden Gate Obstetrics & Gynecology
Clinical Professor-Department of Obstetrics, Gynecology and Reproductive Sciences
University of California, San Francisco
San Francisco, California

Click Here to Read the Supplement. 

Click Here to Read Supplement. 

Topics Include:

• The Role of Cord Blood Stem Cells
• Impact of DCC in Cord Blood Collection
• Combining DCC and Cord Blood Collection
• When to Clamp the Umbilical Cord

Faculty/Faculty Disclosure:

Fung Lam, MD
Chair-GYN Quality, Director of Medical Education (OB-GYN), California-Pacific Medical Center
Senior Partner, Golden Gate Obstetrics & Gynecology
Clinical Professor-Department of Obstetrics, Gynecology and Reproductive Sciences
University of California, San Francisco
San Francisco, California

Click Here to Read the Supplement. 

Supplement Editor:
M. Cecilia Lansang, MD, MPH

Contents

Diabetes and obesity: Managing dual epidemics
M. Cecilia Lansang, MD, MPH

Diabetes with obesity—Is there an ideal diet?
Zahrae Sandouk and M. Cecilia Lansang

The essential role of exercise in the management of type 2 diabetes
John P. Kirwan, Jessica Sacks, and Stephan Nieuwoudt

Optimizing diabetes treatment in the presence of obesity
Mary Angelynne Esquivel and M. Cecilia Lansang

Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?
Bartolome Burguera, Khawla F. Ali, and Juan P. Brito

Metabolic surgery for treating type 2 diabetes mellitus: Now supported by the world's leading diabetes organizations
Philip R. Schauer, Zubaidah Nor Hanipah, and Francesco Rubino

— Bonus Article —Medical Treatment of Diabetes Mellitus
Mario Skugor

Supplement Editor:
M. Cecilia Lansang, MD, MPH

Contents

Diabetes and obesity: Managing dual epidemics
M. Cecilia Lansang, MD, MPH

Diabetes with obesity—Is there an ideal diet?
Zahrae Sandouk and M. Cecilia Lansang

The essential role of exercise in the management of type 2 diabetes
John P. Kirwan, Jessica Sacks, and Stephan Nieuwoudt

Optimizing diabetes treatment in the presence of obesity
Mary Angelynne Esquivel and M. Cecilia Lansang

Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?
Bartolome Burguera, Khawla F. Ali, and Juan P. Brito

Metabolic surgery for treating type 2 diabetes mellitus: Now supported by the world's leading diabetes organizations
Philip R. Schauer, Zubaidah Nor Hanipah, and Francesco Rubino

— Bonus Article —Medical Treatment of Diabetes Mellitus
Mario Skugor

Supplement Editor:
M. Cecilia Lansang, MD, MPH

Contents

Diabetes and obesity: Managing dual epidemics
M. Cecilia Lansang, MD, MPH

Diabetes with obesity—Is there an ideal diet?
Zahrae Sandouk and M. Cecilia Lansang

The essential role of exercise in the management of type 2 diabetes
John P. Kirwan, Jessica Sacks, and Stephan Nieuwoudt

Optimizing diabetes treatment in the presence of obesity
Mary Angelynne Esquivel and M. Cecilia Lansang

Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?
Bartolome Burguera, Khawla F. Ali, and Juan P. Brito

Metabolic surgery for treating type 2 diabetes mellitus: Now supported by the world's leading diabetes organizations
Philip R. Schauer, Zubaidah Nor Hanipah, and Francesco Rubino

— Bonus Article —Medical Treatment of Diabetes Mellitus
Mario Skugor

Click here to access Federal Health Care Data Trends 2017

Table of Contents

• Introduction
• Hematology/Oncology
• Hepatitis C
• Infectious Diseases
• Diabetes Mellitus
• Cardiovascular Disease
• Respiratory Diseases
• Sleep Disorders
• Chronic Pain
• Suicide
• Traumatic Brain Injury
• Women’s Health
• Neurology
• Rheumatology
• References

Click here to access Federal Health Care Data Trends 2017

Table of Contents

• Introduction
• Hematology/Oncology
• Hepatitis C
• Infectious Diseases
• Diabetes Mellitus
• Cardiovascular Disease
• Respiratory Diseases
• Sleep Disorders
• Chronic Pain
• Suicide
• Traumatic Brain Injury
• Women’s Health
• Neurology
• Rheumatology
• References

Click here to access Federal Health Care Data Trends 2017

Table of Contents

• Introduction
• Hematology/Oncology
• Hepatitis C
• Infectious Diseases
• Diabetes Mellitus
• Cardiovascular Disease
• Respiratory Diseases
• Sleep Disorders
• Chronic Pain
• Suicide
• Traumatic Brain Injury
• Women’s Health
• Neurology
• Rheumatology
• References

While type 2 diabetes (T2D) is commonly seen in primary care, it is difficult to control successfully over time. This series offers brief eNewsletters written by clinical experts that are designed to assist in the clinical management of patients with T2D.
 
This fourth eNewsletter in the series, entitled Effect of Non–Insulin-Based Glucose-Lowering Therapies on Cardiovascular Outcomes in Patients With Type 2 Diabetes, was written by Szymon L. Wiernek, MD, PhD, and Matthew A. Cavender, MD, MPH. It presents an overview of commonly used non–insulin-based glucose-lowering drugs in the context of cardiovascular disease risk. The basic mechanisms of action for each pharmacotherapeutic class and the effects of these medications on cardiovascular events are discussed so that physicians can make informed treatment decisions

Click here to read the supplement

While type 2 diabetes (T2D) is commonly seen in primary care, it is difficult to control successfully over time. This series offers brief eNewsletters written by clinical experts that are designed to assist in the clinical management of patients with T2D.
 
This fourth eNewsletter in the series, entitled Effect of Non–Insulin-Based Glucose-Lowering Therapies on Cardiovascular Outcomes in Patients With Type 2 Diabetes, was written by Szymon L. Wiernek, MD, PhD, and Matthew A. Cavender, MD, MPH. It presents an overview of commonly used non–insulin-based glucose-lowering drugs in the context of cardiovascular disease risk. The basic mechanisms of action for each pharmacotherapeutic class and the effects of these medications on cardiovascular events are discussed so that physicians can make informed treatment decisions

Click here to read the supplement

While type 2 diabetes (T2D) is commonly seen in primary care, it is difficult to control successfully over time. This series offers brief eNewsletters written by clinical experts that are designed to assist in the clinical management of patients with T2D.
 
This fourth eNewsletter in the series, entitled Effect of Non–Insulin-Based Glucose-Lowering Therapies on Cardiovascular Outcomes in Patients With Type 2 Diabetes, was written by Szymon L. Wiernek, MD, PhD, and Matthew A. Cavender, MD, MPH. It presents an overview of commonly used non–insulin-based glucose-lowering drugs in the context of cardiovascular disease risk. The basic mechanisms of action for each pharmacotherapeutic class and the effects of these medications on cardiovascular events are discussed so that physicians can make informed treatment decisions

Click here to read the supplement

This newsletter, Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer, provides detailed guidance for nurse practitioners and physician assistants on how to identify, evaluate, and treat patients with poorly controlled, moderate to severe asthma.

Click here to read the supplement

Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska

Kevin R. Murphy, MD

Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
Department of Pediatrics
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska

This newsletter, Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer, provides detailed guidance for nurse practitioners and physician assistants on how to identify, evaluate, and treat patients with poorly controlled, moderate to severe asthma.

Click here to read the supplement

Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska

Kevin R. Murphy, MD

Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
Department of Pediatrics
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska

This newsletter, Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer, provides detailed guidance for nurse practitioners and physician assistants on how to identify, evaluate, and treat patients with poorly controlled, moderate to severe asthma.

Click here to read the supplement

Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska

Kevin R. Murphy, MD

Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
Department of Pediatrics
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska

PART 1

Robert E. Gutman, MD
FPMRS Program Director
MedStar Washington Hospital Center
Associate Professor
Departments of Urology and Obstetrics/Gynecology
Georgetown University
Washington, DC

Elizabeth R. Mueller, MD, MSME
Professor, Departments of Urology and Obstetrics/Gynecology
Loyola University Chicago Stritch School of Medicine
Loyola University Medical Center
Maywood, Illinois

Janet Bickel, MA
Leadership and Career Development Coach
Falls Church, Virginia

Kristin M. Jacobs, MD
Steering Committee Chair, AUGS-SGS Group of FPRN®
FPMRS Fellow, Division of Urogynecology and Reconstructive Pelvic Surgery
Brown University
Providence, Rhode Island

Lior Lowenstein, MD, MS, MHA
Clinical Associate Professor, Department of Obstetrics and Gynecology
Rambam Health Center Campus, Ruth and Bruce Rappaport Faculty of Medicine
Technion Israel Institute of Technology
Haifa, Israel

Drs. Gutman, Jacobs, and Lowenstein and Ms. Bickel report no financial relationships relevant to their articles. Dr. Mueller reports that she is an investigator for and is on the advisory board of Astellas Medical and Scientific Affairs.

Photo: 3D4Medical / Science Source

PART 2

Geoffrey W. Cundiff, MD
Dr. Victor Gomel Professor and Head
Department of Obstetrics and Gynaecology
University of Bristish Columbia
Vancouver, British Columbia

Kimberly Kenton, MD,  MS
Professor, Obstetrics and Gynaecology and Urology
Divison Chief and Fellowship Program Director
Female Pelvis Medicine and Reconstructive Surgery
Medicial Director, Women's Integrated Pelvic Health Program
Northwestern Medicine/Northwestern University Feinberg School of Medicince
Chicago, Illinois

Denise M. Elser, MD
Urogynecologist
Women's Health Institute of Illinois
Oak Lawn, Illinois

Drs. Cundiff and Elser report no financial relationships relevant to their articles. Dr. Kenton reports that she receives grant or research support from Boston Scientific and the National Institutes of Health, and that she serves as an expert witness for the Butler Snow Law Firm/Ethicon.

Illustration: Science Picture Co/ Science Source

PART 1

Robert E. Gutman, MD
FPMRS Program Director
MedStar Washington Hospital Center
Associate Professor
Departments of Urology and Obstetrics/Gynecology
Georgetown University
Washington, DC

Elizabeth R. Mueller, MD, MSME
Professor, Departments of Urology and Obstetrics/Gynecology
Loyola University Chicago Stritch School of Medicine
Loyola University Medical Center
Maywood, Illinois

Janet Bickel, MA
Leadership and Career Development Coach
Falls Church, Virginia

Kristin M. Jacobs, MD
Steering Committee Chair, AUGS-SGS Group of FPRN®
FPMRS Fellow, Division of Urogynecology and Reconstructive Pelvic Surgery
Brown University
Providence, Rhode Island

Lior Lowenstein, MD, MS, MHA
Clinical Associate Professor, Department of Obstetrics and Gynecology
Rambam Health Center Campus, Ruth and Bruce Rappaport Faculty of Medicine
Technion Israel Institute of Technology
Haifa, Israel

Drs. Gutman, Jacobs, and Lowenstein and Ms. Bickel report no financial relationships relevant to their articles. Dr. Mueller reports that she is an investigator for and is on the advisory board of Astellas Medical and Scientific Affairs.

Photo: 3D4Medical / Science Source

PART 2

Geoffrey W. Cundiff, MD
Dr. Victor Gomel Professor and Head
Department of Obstetrics and Gynaecology
University of Bristish Columbia
Vancouver, British Columbia

Kimberly Kenton, MD,  MS
Professor, Obstetrics and Gynaecology and Urology
Divison Chief and Fellowship Program Director
Female Pelvis Medicine and Reconstructive Surgery
Medicial Director, Women's Integrated Pelvic Health Program
Northwestern Medicine/Northwestern University Feinberg School of Medicince
Chicago, Illinois

Denise M. Elser, MD
Urogynecologist
Women's Health Institute of Illinois
Oak Lawn, Illinois

Drs. Cundiff and Elser report no financial relationships relevant to their articles. Dr. Kenton reports that she receives grant or research support from Boston Scientific and the National Institutes of Health, and that she serves as an expert witness for the Butler Snow Law Firm/Ethicon.

Illustration: Science Picture Co/ Science Source

PART 1

Robert E. Gutman, MD
FPMRS Program Director
MedStar Washington Hospital Center
Associate Professor
Departments of Urology and Obstetrics/Gynecology
Georgetown University
Washington, DC

Elizabeth R. Mueller, MD, MSME
Professor, Departments of Urology and Obstetrics/Gynecology
Loyola University Chicago Stritch School of Medicine
Loyola University Medical Center
Maywood, Illinois

Janet Bickel, MA
Leadership and Career Development Coach
Falls Church, Virginia

Kristin M. Jacobs, MD
Steering Committee Chair, AUGS-SGS Group of FPRN®
FPMRS Fellow, Division of Urogynecology and Reconstructive Pelvic Surgery
Brown University
Providence, Rhode Island

Lior Lowenstein, MD, MS, MHA
Clinical Associate Professor, Department of Obstetrics and Gynecology
Rambam Health Center Campus, Ruth and Bruce Rappaport Faculty of Medicine
Technion Israel Institute of Technology
Haifa, Israel

Drs. Gutman, Jacobs, and Lowenstein and Ms. Bickel report no financial relationships relevant to their articles. Dr. Mueller reports that she is an investigator for and is on the advisory board of Astellas Medical and Scientific Affairs.

Photo: 3D4Medical / Science Source

PART 2

Geoffrey W. Cundiff, MD
Dr. Victor Gomel Professor and Head
Department of Obstetrics and Gynaecology
University of Bristish Columbia
Vancouver, British Columbia

Kimberly Kenton, MD,  MS
Professor, Obstetrics and Gynaecology and Urology
Divison Chief and Fellowship Program Director
Female Pelvis Medicine and Reconstructive Surgery
Medicial Director, Women's Integrated Pelvic Health Program
Northwestern Medicine/Northwestern University Feinberg School of Medicince
Chicago, Illinois

Denise M. Elser, MD
Urogynecologist
Women's Health Institute of Illinois
Oak Lawn, Illinois

Drs. Cundiff and Elser report no financial relationships relevant to their articles. Dr. Kenton reports that she receives grant or research support from Boston Scientific and the National Institutes of Health, and that she serves as an expert witness for the Butler Snow Law Firm/Ethicon.

Illustration: Science Picture Co/ Science Source